Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

186 ta ish

Ish: Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

  1. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer

    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6

    Sharh maqola20218 iqtibos
    ABI

  2. Cancer stem cells: advances in knowledge and implications for cancer therapy

    Xianjing Chu, Wentao Tian, Jiaoyang Ning +7

    Maqola20248 iqtibos
    ABI

  3. Prospective identification of tumorigenic breast cancer cells

    Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández +2

    Maqola20037 iqtibos
    ABI

  4. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Maqola20216 iqtibos
    ABI

  5. Cancer stem cells: landscape, challenges and emerging therapeutic innovations

    Haksoo Lee, Byeongsoo Kim, Junhyeong Park +7

    Sharh maqola20256 iqtibos
    ABI

  6. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

    Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7

    Sharh maqola20196 iqtibos
    ABI

  7. EP4 receptor as a novel promising therapeutic target in colon cancer

    Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5

    Sharh maqola20206 iqtibos
    ABI

  8. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

    Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11

    Maqola20246 iqtibos
    ABI

  9. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

    Zhou Chen, Fangfang Han, Yan Du +2

    Sharh maqola20236 iqtibos
    ABI

  10. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    MaqolaOchiq kirish20235 iqtibos
    ABI

  11. The role of Th17 cells in the pathogenesis and treatment of breast cancer

    Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5

    Sharh maqola20225 iqtibos
    ABI

  12. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

    Karin E. de Visser, Johanna A. Joyce

    Sharh maqola20235 iqtibos
    ABI

  13. The molecular biology and therapeutic potential of Nrf2 in leukemia

    Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6

    Sharh maqola20225 iqtibos
    ABI

  14. Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

    Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11

    MaqolaOchiq kirish20224 iqtibos
    ABI

  15. RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

    Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11

    Maqola20214 iqtibos
    ABI

  16. Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

    Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4

    Sharh maqola20234 iqtibos
    ABI

  17. Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice

    Ghasem Ghalamfarsa, Ali Rastegari, Fatemeh Atyabi +11

    Maqola20184 iqtibos
    ABI

  18. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

    Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

    Maqola20254 iqtibos
    ABI

  19. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression

    Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani +12

    Maqola20204 iqtibos
    ABI

  20. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

    Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

    Sharh maqola20224 iqtibos
    ABI

  21. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

    Tsvee Lapidot, Christian Sirard, Josef Vormoor +7

    MaqolaOchiq kirish19943 iqtibos
    ABI

  22. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

    Brian Keith, Randall S. Johnson, M. Celeste Simon

    Sharh maqola20113 iqtibos
    ABI

  23. Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

    Yin Wang, Yan Liu, Sami N. Malek +2

    Maqola20113 iqtibos
    ABI

  24. Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

    Zhizhong Li, Shideng Bao, Qiulian Wu +9

    Maqola20093 iqtibos
    ABI

  25. T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer

    Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov +5

    Sharh maqola20213 iqtibos
    ABI